Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the de novo paradigm in sporadic early-onset Alzheimer disease trios.

Molecular psychiatry·2026
Same author

Photoinduced granulomatous drug reaction related to lamotrigine.

JAAD case reports·2026
Same author

Language performances in dementia with Lewy bodies and Alzheimer's disease: A longitudinal comparative study of naming and fluency.

Journal of Alzheimer's disease : JAD·2026
Same author

CSF elevated Tau and P-Tau and normal Aβ42 mainly corresponds to Alzheimer's disease with dementia with Lewy bodies.

GeroScience·2026
Same author

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics·2026
Same author

Telomere shortening in laminopathic dilated cardiomyopathy.

NPJ Regenerative medicine·2026
Same journal

Clinical outcomes after antipsychotic discontinuation in nursing home residents with dementia: a nationwide cohort study.

Alzheimer's research & therapy·2026
Same journal

Chronic pain as a risk factor for Alzheimer's disease pathology: a longitudinal ADNI study.

Alzheimer's research & therapy·2026
Same journal

γ-radiation reduces phosphorylated-tau in rhesus macaque brains: potential implications for Alzheimer's disease and other tauopathies.

Alzheimer's research & therapy·2026
Same journal

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

Alzheimer's research & therapy·2026
Same journal

Smoking cessation duration and risk of Alzheimer's disease: a nationwide cohort study in Korea.

Alzheimer's research & therapy·2026
Same journal

Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA).

Alzheimer's research & therapy·2026
See all related articles

Related Experiment Video

Updated: Jul 30, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K

Phenotype and imaging features associated with APP duplications.

Lou Grangeon1,2, Camille Charbonnier3, Aline Zarea4

  • 1Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France. lou.grangeon@chu-rouen.fr.

Alzheimer'S Research & Therapy
|May 11, 2023
PubMed
Summary
This summary is machine-generated.

APP duplication, a rare genetic cause of Alzheimer disease, leads to diverse neurological symptoms including dementia, hemorrhage, and seizures. This genetic mutation results in severe amyloid buildup in cerebral vessels, characteristic of cerebral amyloid angiopathy.

Keywords:
APP duplicationAlzheimer diseaseAutosomal dominantCerebral MRICerebral amyloid angiopathy

More Related Videos

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

19.7K
Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
11:47

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer

Published on: February 8, 2013

12.0K

Related Experiment Videos

Last Updated: Jul 30, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K
Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

19.7K
Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
11:47

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer

Published on: February 8, 2013

12.0K

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Amyloid precursor protein (APP) duplication is a rare genetic cause of Alzheimer disease (AD) and cerebral amyloid angiopathy (CAA).
  • Understanding the diverse clinical and radiological presentations of APP duplication carriers is crucial for diagnosis and management.

Purpose of the Study:

  • To evaluate the phenotypes of individuals carrying APP duplications.
  • To compare the features of APP duplication carriers with APP-negative cerebral amyloid angiopathy controls.

Main Methods:

  • Retrospective analysis of clinical, radiological, and neuropathological data from 43 APP duplication carriers across 24 French families.
  • Comparison of MRI features and cerebrospinal fluid (CSF) biomarkers between carriers and 40 APP-negative CAA controls.

Main Results:

  • 90.2% of symptomatic carriers developed major neurocognitive disorders, with 29.2% experiencing intracerebral hemorrhages and 51.2% seizures.
  • CSF Aβ42 levels were abnormal in most carriers (18/19), and 14/19 met MRI criteria for CAA.
  • Neuropathology revealed diffuse and severe CAA with thickened leptomeningeal vessels in all autopsied cases; Lewy bodies were found in some.

Conclusions:

  • APP duplications present heterogeneous phenotypes, including dementia, hemorrhage, and seizures, with varied radiological findings.
  • The amyloid burden is severe and widespread in cerebral vessels, positioning APP duplication as a significant model for studying CAA.
  • No correlation was found between duplication size and CAA radiological signs.